Canada Drugs Direct

Visiting from Canada?

Want to save up to 80% on your medications? Signup below to be notified if we open a Canadian Online Pharmacy.

I agree to receive email updates from Canada Drugs Direct

Looking for Call us toll free 1-800-500-2897

Brilinta (Ticagrelor)

Also Known as Brilique

Prescription medicineOnly Available By Prescription

Top brand choice

Strength Pack Size Qty
Pack Size
Pack Size

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using

Top Generic choice

Strength Pack Size Qty
Pack Size
Pack Size

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. The must be a member of CIPA (Canadian International Pharmacy Association).
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.


Brilinta (ticagrelor) is a medication prescribed to decrease the risk of:

  • cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome (ACS) or a history of a heart attack.
  • stent thrombosis, or occlusion, in ACS patients.
  • a first heart attack or stroke in patients who have coronary artery disease (CAD) and are at high risk of these events.
  • stroke in patients who have acute ischemic stroke or high-risk transient ischemic attack (TIA).

Brilinta comes in 60 mg and 90 mg tablets for oral administration.

Fact Table




FDA approved


36% (Ticagrelor), 88% (active metabolite)

Legal status

Prescription drug

Chemical Name


Elimination half-life

7 hours (Ticagrelor), 8.5 hours (active metabolite)

Dosage (Strength)

Tablets; 60 mg, 90 mg

Pregnancy advice

Consult a doctor - Category C (US)


Brilinta, Possia

Protein binding


PubChem CID






ATC code






Routes of administration



Take Brilinta exactly as your doctor has prescribed. Discuss any questions or concerns you have about the medication with your doctor or pharmacist.

Each patient’s dose of Brilinta is based on the condition being treated and is recommended to be taken with aspirin. Your doctor will tell you how much Brilinta and aspirin is right for you.


Ticagrelor is the active ingredient in Brilinta.

Mannitol, dibasic calcium phosphate, sodium starch glycolate, hydroxypropyl cellulose, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, polyethylene glycol 400, ferric oxide black, and ferric oxide red are the inactive ingredients in the 60 mg tablets.

Mannitol, dibasic calcium phosphate, sodium starch glycolate, hydroxypropyl cellulose, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, talc, polyethylene glycol 400, and ferric oxide yellow are the inactive ingredients in the 90 mg tablets.


The administration of Brilinta should be avoided in patients who have had bleeding in the brain, active bleeding, or an allergy to ticagrelor or to any of its components.


Brilinta has an FDA Boxed Warning regarding the risk of significant bleeding that can be fatal. Patients with active pathological bleeding or a history of brain bleeding should not take Brilinta. In addition, patients undergoing urgent coronary artery bypass graft surgery (CABG) should not take Brilinta. Because stopping Brilinta can increase the risk of cardiovascular events, bleeding should be managed without stopping Brilinta, if possible.

Brilinta also has an FDA Boxed Warning against taking aspirin in doses of 100 mg or more with Brilinta, as doing so can decrease the effects of Brilinta.

  • Before you start taking Brilinta, tell your doctor:
    • About all the medications you take, including prescription medications, herbals, vitamins, and supplements.
    • About your allergies.
    • About your current health problems and past medical history.
    • If you are pregnant or breastfeeding.
  • Patients may experience shortness of breath with Brilinta treatment.
  • Patients should stop Brilinta only if their doctor has instructed them to do so.
  • Patients may experience abnormal slow heart rhythms with Brilinta treatment.
  • Brilinta should not be administered to patients with severe liver problems.
  • Brilinta treatment may cause central sleep apnea.
  • Certain laboratory tests can be affected by Brilinta.

Side Effects

Bleeding and shortness of breath are common Brilinta medication side effects; however, patients may experience other side effects as well. If you experience side effects that concern you or won’t go away, contact your doctor immediately.


Brilinta (ticagrelor). Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2022.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product-reviews Product Reviews